James P. Allison

Taiwan's 2020 Tang Prize Biopharmaceutical Science Laureates to Decipher the Code of Body's Inflammatory Responses

Monday, September 14, 2020 - 1:00pm

The Tang Prize Foundation, in collaboration with Experimental Biology of the US and Taiwan's National Cheng Kung University, will stage the 2020 Tang Prize Masters' Forum for Biopharmaceutical Science at 9a.m., Taiwan time (GMT+8), on September 22, and livestream it on the Foundation's website (https://www.tang-prize.org/en/week.php?cat=94 ), with both Mandarin and English settings available.

Key Points: 
  • The Tang Prize Foundation, in collaboration with Experimental Biology of the US and Taiwan's National Cheng Kung University, will stage the 2020 Tang Prize Masters' Forum for Biopharmaceutical Science at 9a.m., Taiwan time (GMT+8), on September 22, and livestream it on the Foundation's website (https://www.tang-prize.org/en/week.php?cat=94 ), with both Mandarin and English settings available.
  • In addition to the lectures delivered by three 2020 awardees, 2014 Tang Prize and 2018 Nobel Prize winners Dr. James P. Allison and Prof. Tasuku Honjo will also take part.
  • Harkening back to the golden age of the Tang Dynasty in Chinese history, the Tang Prize seeks to be an inspiring force for people working in all corners of the world.
  • For more information on the Tang Prize and its laureates, please visit www.tang-prize.org

Bill Haney's Critically Acclaimed Documentary Jim Allison: Breakthrough Premieres Tonight On PBS

Monday, April 27, 2020 - 2:00pm

Praised for its heartfelt and accessible storytelling of one warm-hearted scientist's quest to find a cure for cancer, Jim Allison: Breakthrough presents a new kind of heroDr.

Key Points: 
  • Praised for its heartfelt and accessible storytelling of one warm-hearted scientist's quest to find a cure for cancer, Jim Allison: Breakthrough presents a new kind of heroDr.
  • Jim Allison, who waged a decades-long struggle to bring a novel cancer treatment to patients worldwide.
  • "Jim Allison: Breakthrough reminds us all to keep pushing and fighting if we believe in something, despite adversity.
  • Founded in 2000 by Tim Disney and Bill Haney, Uncommon Productions produces documentary and feature films that inspire, enlighten, and engage.

Jim Allison: Breakthrough Documentary to Open in Theaters on September 27th

Wednesday, September 25, 2019 - 2:00pm

Boston, MA, Sept. 25, 2019 (GLOBE NEWSWIRE) -- Uncommon Productions (Uncommon) will premiere their latest documentary, Jim Allison: Breakthrough (Breakthrough) in New York and Los Angeles on Friday, September 27th, before expanding to theaters across the country .

Key Points: 
  • Boston, MA, Sept. 25, 2019 (GLOBE NEWSWIRE) -- Uncommon Productions (Uncommon) will premiere their latest documentary, Jim Allison: Breakthrough (Breakthrough) in New York and Los Angeles on Friday, September 27th, before expanding to theaters across the country .
  • The scientific revolution that Jim has sparked in immuno-oncology is changing the lives of millions of patients and their families, worldwide.
  • For more information on Jim Allison: Breakthrough, visit www.breakthroughdoc.com , or follow Jim Allison: Breakthrough on Facebook , Twitter , or Instagram .
  • Founded in 2000 by Tim Disney and Bill Haney, Uncommon Productions produces documentary and feature films that inspire, enlighten, and engage.

Lytix Biopharma AS Announces the Addition of Nobel Laureate Dr James Allison and Oncologist Dr Padmanee Sharma From the MD Anderson Cancer Center to its SAB and as Company Strategic Advisors

Thursday, June 13, 2019 - 11:30am

His research elucidated the mechanism behind T cell activation and pioneered the first immune checkpoint blocker drug for the treatment of cancer.

Key Points: 
  • His research elucidated the mechanism behind T cell activation and pioneered the first immune checkpoint blocker drug for the treatment of cancer.
  • Dr Allison was jointly awarded the Nobel Prize in Physiology or Medicine for this work in 2018.
  • His current research is focused on improving the utility of checkpoint blockade and identifying new targets to unleash the immune system to eradicate cancer.
  • Dr Padmanee (Pam) Sharma (MD) is a prominent leader in oncology specialising in kidney, bladder and prostate cancer.

Lytix Biopharma AS Announces the Addition of Nobel Laureate Dr James Allison and Oncologist Dr Padmanee Sharma From the MD Anderson Cancer Center to its SAB and as Company Strategic Advisors

Thursday, June 13, 2019 - 11:24am

His research elucidated the mechanism behind T cell activation and pioneered the first immune checkpoint blocker drug for the treatment of cancer.

Key Points: 
  • His research elucidated the mechanism behind T cell activation and pioneered the first immune checkpoint blocker drug for the treatment of cancer.
  • Dr Allison was jointly awarded the Nobel Prize in Physiology or Medicine for this work in 2018.
  • His current research is focused on improving the utility of checkpoint blockade and identifying new targets to unleash the immune system to eradicate cancer.
  • Dr Padmanee (Pam) Sharma (MD) is a prominent leader in oncology specialising in kidney, bladder and prostate cancer.

Hummingbird Bioscience Announces Nobel Laureate Dr. James Allison and Dr. Padmanee Sharma Join its Scientific Advisory Board

Monday, February 18, 2019 - 12:30pm

SINGAPORE, Feb. 18, 2019 /PRNewswire/ -- Hummingbird Bioscience , a systems-biology enabled biotech company focused on the discovery and development of novel cancer therapeutics, today announced James P. Allison, Ph.D. and Padmanee Sharma, M.D., Ph.D., have joined its Scientific Advisory Board.

Key Points: 
  • SINGAPORE, Feb. 18, 2019 /PRNewswire/ -- Hummingbird Bioscience , a systems-biology enabled biotech company focused on the discovery and development of novel cancer therapeutics, today announced James P. Allison, Ph.D. and Padmanee Sharma, M.D., Ph.D., have joined its Scientific Advisory Board.
  • "I am pleased to join the Scientific Advisory Board of Hummingbird Bioscience at this exciting moment in the development of its pipeline ," said Dr. Allison.
  • "It is wonderful opportunity to be a part of the Hummingbird Bioscience Scientific Advisory Board," said Dr. Sharma.
  • Allison and Sharma join our board of scientific advisors," said Piers Ingram , Ph.D., CEO of Hummingbird Bioscience.

Dave Hilfman Named Co-Recipient of GAC's Person of the Year

Friday, November 30, 2018 - 9:35pm

This year GAC names co-recipients for that honor -- Dr. Jim Allison, 2018 Nobel Laureate for Medicine with M.D.

Key Points: 
  • This year GAC names co-recipients for that honor -- Dr. Jim Allison, 2018 Nobel Laureate for Medicine with M.D.
  • Anderson Cancer Center and United Airlines Executive Dave Hilfman.
  • United Airlines, and prior to that Continental, has been title sponsor for GAC since its founding in 1997.
  • Dave Hilfman is senior vice president of worldwide sales for United.

Two Fellows of the National Academy of Inventors Win Nobel Prizes

Thursday, October 25, 2018 - 1:45pm

TAMPA, Fla., Oct. 25, 2018 /PRNewswire/ --James P. Allison, Ph.D., and Frances H. Arnold, Ph.D., both Fellows of the National Academy of Inventors (NAI), were awarded the Nobel Prizes in Medicine and Chemistry, respectively.

Key Points: 
  • TAMPA, Fla., Oct. 25, 2018 /PRNewswire/ --James P. Allison, Ph.D., and Frances H. Arnold, Ph.D., both Fellows of the National Academy of Inventors (NAI), were awarded the Nobel Prizes in Medicine and Chemistry, respectively.
  • Allison was jointly awarded the Nobel Prize in Medicine, sharing the honor with Dr. Tasuku Honjo of Kyoto University.
  • She was also inducted into the National Inventors Hall of Fame in 2014, and she received the National Medal of Technology and Innovation in 2011.
  • The National Academy of Inventors is a member organization comprising U.S. and international universities, and governmental and non-profit research institutes, with over 4,000 individual inventor members and Fellows spanning more than 250 institutions worldwide.

TapImmune Expands Scientific Advisory Board with Cancer Immunotherapy Pioneers James P. Allison, Ph.D., and Padmanee Sharma, M.D., Ph.D., from the MD Anderson Cancer Center

Tuesday, May 22, 2018 - 11:30am

Dr. Allison also serves as the Chair of MD Anderson's Department of Immunology and Director of its Immunotherapy Platform.

Key Points: 
  • Dr. Allison also serves as the Chair of MD Anderson's Department of Immunology and Director of its Immunotherapy Platform.
  • Padmanee Sharma, M.D., Ph.D., is a leading translational scientist and clinical investigator focused on cancer immunotherapy.
  • "I am thrilled to welcome Dr. Allison and Dr. Sharma to our Scientific Advisory Board," said Peter L. Hoang, President & CEO of TapImmune.
  • "In many ways, Dr. Allison's scientific contributions have made cancer immunotherapy, as we understand it today, possible.